ATXN2 and spinocerebellar ataxia type 2: Ultimately, a mix of protein-protein interactions and posttranslational modifications impact ataxin-2 and its ability to cause malfunction and neurodegeneration in its polyQ-expanded form in SCA2 and also in other diseases of the nervous system.